Stetoskop
Stetoskop
Đorđe Jevtović

Prof. dr Đorđe Jevtović

Lekar opšte medicine

Prof. dr Đorđe Jevtović, rođen 1953. godine u Beogradu, lekar-infektolog. Profesor je Medicinskog fakulteta i načelnik centra za HIV na Klinici za infektologiju i tropske bolesti u Beogradu.

BeogradJezici: Srpski, Engleski

Zakažite pregled

Kod ovog lekara trenutno nije moguće zakazati pregled online. Pozovite nas i pomoći ćemo Vam da pronađete termin.

063/687-460

O lekaru

Prof. dr Đorđe Jevtović, rođen 1953. godine u Beogradu, lekar-infektolog. Profesor je Medicinskog fakulteta i načelnik centra za HIV na Klinici za infektologiju i tropske bolesti u Beogradu. Dr Jevtović je objavio 208 publikacija kojima su obuhvaćene različite oblasti infektologije.

Prof. dr Đorđe Jevtović je u penziji.

Radno iskustvo

Medicinski fakultet Beograd

Profesor.

Klinika za infektologiju i tropske bolesti u Beogradu

Načelnik centra za HIV.

Obrazovanje

Medicinski fakultet u Beogradu

(1978) Osnovne studije.

Članstva

Podaci o članstvima nisu uneti.

Ocene i iskustva

Još uvek nema ocena.

Najnoviji članci koje je lekar objavio:

Svi odgovori doktora (6238)

?
Pitanje #23599819. 12. 2024.
Đorđe Jevtović
Đorđe JevtovićSpecijalista infektologije
Zakažite

šta ko kaže je malo važno, tačno je ono što u udžbenicima piše, a virusloška dijagnostika podrazumeva serološku i molekularnu, koja  prema vodiču dobre prakse izgleda ovako:

  • HIV antibody testing with or without HIV P24 antigen tests

  • Nucleic acid amplification assays to determine HIV RNA level (viral load)

HIV infection is suspected in patients with persistent, unexplained, generalized adenopathy or any of the AIDS-defining illnesses (see sidebar AIDS-Defining Illnesses). It may also be suspected in high-risk patients with symptoms that could represent acute primary HIV infection.

Diagnostic tests

Detection of antibodies to HIV is sensitive and specific except during the first few weeks after infection (termed the "window period" of acute HIV infection). However, the HIV p24 antigen (a core protein of the virus) is already present in the blood during most of this time and can be detected by assays.

Currently, a fourth-generation antigen/antibody combination immunoassay is recommended; it detects antibodies to both HIV-1 and HIV-2 as well as the p24 HIV antigen. The laboratory version is probably preferred over the point-of-care test for diagnosing early infection, but both can be done quickly (within 30 minutes). If the test result is positive, an assay to differentiate HIV-1 and HIV-2 and an HIV RNA assay are done.

Earlier-generation enzyme-linked immunosorbent assay (ELISA) antibody assays are highly sensitive, but because they do not test for antigen, they are not positive as early as the fourth-generation combination test. Also, results are rarely false-positive. Positive ELISA results are therefore confirmed with a more specific test such as Western blot. However, these tests have drawbacks:

  • ELISA requires complex equipment.

  • Western blot requires well-trained technicians, is expensive, and takes several days or weeks for results to be available.

  • The full testing sequence takes at least a day.

Most settings use an HIV-1/HIV-2 differentiation assay as their preferred confirmatory test, replacing the cumbersome Western blot. Additionally, HIV-1 Western blot assays do not reliably detect subtype O virus prevalent in some African regions; if HIV-2 is being considered, a special HIV-2 Western blot needs to be requested (1). Point-of-care tests using blood or saliva (eg, particle agglutination, immunoconcentration, immunochromatography) can be done quickly (in 15 minutes) and simply, allowing testing in a variety of settings and immediate reporting to patients. Positive results of these rapid tests should be confirmed by standard blood tests (eg, ELISA with or without Western blot) in high-resource countries and repetition with one or more other rapid tests in high HIV burden countries. Negative tests need not be confirmed.

If HIV infection is suspected despite negative antibody test results (eg, during the first few weeks after infection), the plasma HIV RNA level should be measured. The nucleic acid amplification assays used are highly sensitive and specific. HIV RNA assays require advanced technology, such as reverse transcription–polymerase chain reaction (RT-PCR), which is sensitive to extremely low HIV RNA levels. Measuring p24 HIV antigen by ELISA is less sensitive and less specific than directly detecting HIV RNA in blood.

?
Pitanje #23595017. 12. 2024.
Đorđe Jevtović
Đorđe JevtovićSpecijalista infektologije
Zakažite

coxackie virus izaziva mnogobrojne lake i teške blesti(od blagih respiratornih infekcija, osipnih goznica, pleurodinije, do mioperikarditisa, meningitisa...).Karditis može imati samo akutni oblik,koji spontano prolazi, ali retko dovodii do dlatirajuće kardiomiopatije, teške hronične bolesti. Febrilnost prati samo akutnu fazu. EBV , uzročnik infektivne mononukleoze retko ima hronični oblik.

?
Pitanje #23594717. 12. 2024.
Đorđe Jevtović
Đorđe JevtovićSpecijalista infektologije
Zakažite

nije, ako slina ne sadrži vidljivu krv- a takav način sticanja ove infekcje nije verovatan, to je prevashodno plno prenosiva infekcija, i/ili putem krvi

Pitajte doktora

Imate nedoumicu u vezi sa svojim zdravljem? Postavite pitanje i dobijte odgovor lekara u najkraćem roku.

Dozvoljeni formati: JPG, PNG, WebP, PDF, DOC, DOCX. Maks. 10MB po fajlu.

Na ovu email adresu ćemo vam poslati odgovor i uputstvo za praćenje statusa.

Stetoskop Gazette

Prijavite se na Stetoskop Gazette

Mesečni bilten o zdravlju, inovacijama i svemu aktuelnom u medicini.

Pozovite nas i zakažite pregled

063 / 687 - 460